Literature DB >> 10357115

A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history.

K O Forseth1, O Førre, J T Gran.   

Abstract

In order to investigate the significance and outcome of self-reported pain and fibromyalgia (FM) in a female population, 214 women with initially self-reported pain were interviewed and examined in 1990 and 1995. In 1990 the sample was categorised into four pain status groups: 46 individuals (21%) with nonchronic (recurrent) pain, 69 (32%) with chronic regional pain 42 (20%) with chronic multifocal pain and 57 with chronic widespread pain (CWP). The last group comprised 39 (18%) women with FM, fulfilling the American College of Rheumatology 1990 criteria. The frequency of tender points, associated symptoms called historical variables and individuals with low education increased statistically significantly with increasing pain status. In 1995, 48 women had non-chronic pain (23%), 46 (21%) chronic regional pain, 39 (18%) chronic multifocal pain and 81 (38%) CWP; of these, 71 (33%) had FM. Eleven of the 39 women initially with FM no longer fulfilled the criteria. The risk of developing CWP among the 157 individuals with initially a lower pain status was statistically higher in women with chronic multifocal pain than in women with less pain extension. Self-reported pain constitutes a continuum of pain severity and thus of clinical and social significance. The overall outcome was poor with an increase of individuals with CWP and FM. The prognosis of chronic multifocal pain, CWP and FM was especially poor. About half of the women with non-chronic pain or chronic regional pain did not deteriorate. However, because the process of developing FM started with localised pain in most cases, self-reported pain of any severity confers a risk for developing FM. Identifying possible risk factors for FM are at present under study and will be presented separately in another report.

Entities:  

Mesh:

Year:  1999        PMID: 10357115     DOI: 10.1007/s100670050067

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

2.  Multiple Nonspecific Sites of Joint Pain Outside the Knees Develop in Persons With Knee Pain.

Authors:  David T Felson; Jingbo Niu; Emily K Quinn; Tuhina Neogi; Cara L Lewis; Cora E Lewis; Laura Frey Law; Chuck McCulloch; Michael Nevitt; Michael LaValley
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

3.  Chronic Pain in a Biracial Cohort of Young Women.

Authors:  Octavia Plesh; Stuart A Gansky; Donald A Curtis
Journal:  Open Pain J       Date:  2012

4.  The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study.

Authors:  Chan-Jin Choi; Raymond Knutsen; Keiji Oda; Gary E Fraser; Synnove Fonnebo Knutsen
Journal:  J Pain       Date:  2010-04-18       Impact factor: 5.820

Review 5.  Management of fibromyalgia: what are the best treatment choices?

Authors:  Karin Ø Forseth K; Jan T Gran
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  The role of psychiatric disorders in fibromyalgia.

Authors:  J McBeth; A J Silman
Journal:  Curr Rheumatol Rep       Date:  2001-04       Impact factor: 4.592

7.  Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia.

Authors:  Dan S Heffez; Ruth E Ross; Yvonne Shade-Zeldow; Konstantinos Kostas; Sagar Shah; Robert Gottschalk; Dean A Elias; Alan Shepard; Sue E Leurgans; Charity G Moore
Journal:  Eur Spine J       Date:  2004-04-09       Impact factor: 3.134

Review 8.  [Fibromyalgia--the new guideline].

Authors:  W Brückle
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

9.  Treatment of cervical myelopathy in patients with the fibromyalgia syndrome: outcomes and implications.

Authors:  Dan S Heffez; Ruth E Ross; Yvonne Shade-Zeldow; Konstantinos Kostas; Mary Morrissey; Dean A Elias; Alan Shepard
Journal:  Eur Spine J       Date:  2007-04-11       Impact factor: 3.134

Review 10.  [Musculoskeletal pain in the population].

Authors:  T Kohlmann
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.